Sentences and paragraphs of SWKS's Risk Factors and MD&A, 10-K Nov 10, 2026 against 10-K Nov 7, 2025.
Each links to the text at sec.gov.
Show the other 16
RewordedRisk Factors
Efforts to complete the Mergers integrate Qorvo could disrupt our relationships with third parties and employees, employees and divert management’s attention, or result in negative publicity or legal proceedings, any of which could adversely impact our operating results and ongoing business.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedRisk Factors
In addition, certain of our products that we use contain firmware that incorporates or is derived from “open source” software that generally is made publicly available by its developers or other third parties.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedRisk Factors
Additionally, on May 21, 2021, the Company entered into a revolving credit agreement with various financial institutions, as lenders, and JPMorgan Chase Bank, N.A., as administrative agent, providing for a $750 million revolving credit facility (the “Revolving Credit Facility”). Facility”), which was amended in November 2025 to extend its maturity date to November 18, 2030.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedRisk Factors
In May 2021, the Company issued in a public offering $500 million of 1.80% Senior Notes due 2026 and $500 million of 3.00% Senior Notes due 2031 (collectively, the “Notes”), (the “2031 Notes”), which 2031 Notes remain outstanding.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedMD&A
We recorded a provision for income taxes of $41.6 million (which consisted of a benefit of $43.9 million and $0.1 million related to United States federal and state income taxes, respectively, and a provision of $85.6 million related to foreign income taxes) and $49.6 million (which consisted of a benefit of $35.5 million and a provision of $0.1 million related to United States federal and state income taxes, respectively, and a provision of $85.0 million related to foreign income taxes) and $40.4 million (which consisted of benefits of $41.5 million and $0.3 million related to United States federal and state income taxes, respectively, and a provision of $82.2 million related to foreign income taxes) in fiscal 2025 2026 and fiscal 2024, 2025, respectively.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedMD&A
The $455.1 $2,303.3 million increase in cash used in provided by financing activities for fiscal 2025, 2026, as compared to fiscal 2024, 2025, was primarily related to an increase of $752.9 $1,979.9 million in long-term debt issued, a decrease of $715.7 million in share repurchases, net of excise tax paid, and a decrease of $112.5 million in dividend payments, partially offset by a decrease an increase of $300.0 $500.0 million for the repayment of debt.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedMD&A
The $121.9 $99.7 million decrease in cash used in investing activities for fiscal 2025, 2026, as compared to fiscal 2024, 2025, was primarily related to an increase a decrease of $531.8 $585.8 million in purchases of marketable securities, partially offset by a decrease of $358.1 million in the sale or maturity of marketable securities, partially offset by an increase of $362.6 million in purchases of marketable securities and an increase of $38.0 $125.6 million in capital expenditures.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedMD&A
We have outstanding $800.0 million of 2028 Notes, $500.0 million of Notes Due 2026 and $500.0 due 2031 (the “2031 Notes”), $600.0 million of Notes Due 2031 (the “Notes”). 2032 Notes, and $600.0 million of 2036 Notes.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedMD&A
Research and development 21.1 19.2 15.1 12.7 Selling, general, and administrative 11.0 9.1 7.2 6.6 Amortization of intangibles — — 0.7 — Restructuring, impairment, and other charges 3.1 0.6 3.6 0.6 Total operating expenses 35.2 28.9 25.9 20.6 Operating income 5.5 12.2 15.3 23.6 Interest expense (1.0) (0.7) (0.7) (1.3) Other income, net 1.0 1.3 0.7 0.4 Income before income taxes 5.4 12.9 15.2 22.6 Provision for income taxes 1.1 1.2 1.0 2.0 Net income 4.3 % 11.7 % 14.3 % 20.6% 14.3%
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedMD&A
Fiscal Years Ended (in millions) October 2, 2026 October 3, 2025 September 27, 2024 September 29, 2023 Cash and cash equivalents at beginning of period $ 1,161.3 $ 1,368.6 $ 718.8 $ 566.0 Net cash provided by operating activities 549.9 1,300.8 1,824.7 1,856.4 Net cash used in investing activities (134.3) (234.0) (355.9) (224.4) Net cash used in provided by (used in) financing activities 1,029.2 (1,274.1) (819.0) (1,479.2) Cash and cash equivalents at end of period $ 2,606.1 $ 1,161.3 $ 1,368.6 $ 718.8
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedMD&A
The increase in selling, general, and administrative expenses in fiscal 2025, 2026, as compared to fiscal 2024, 2025, was primarily related to increases in professional services costs related to the Qorvo transaction, partially offset by decreases in headcount-related expenses, including share-based compensation and increases in professional services costs. compensation.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedMD&A
The decrease in gross profit in fiscal 2025, 2026, as compared to fiscal 2024, 2025, was primarily the result of increases in input costs and unfavorable product mix, lower average selling prices, and an increase in costs associated with facility consolidation and closure, partially offset by higher unit volumes.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedMD&A
Under the terms of the Merger Agreement, at the effective time of the Mergers, transaction, each share of Qorvo common stock issued and outstanding immediately prior thereto (with to the effective time, subject to certain exceptions set forth in the Merger Agreement) will be Agreement, was converted into the right to receive 0.960 (the “Exchange Ratio”) of a share of Skyworks common stock and $32.50 per share in cash, without interest, interest and subject to applicable withholding taxes.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedMD&A
The $523.9 $750.9 million decrease in cash provided by operating activities for fiscal 2025, 2026, as compared to fiscal 2024, 2025, was primarily related to a decrease in cash inflows as a result of changes to working capital (net of $370.7 cash) of $470.8 million, due primarily to inventory and accounts receivable, and lower net income.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedMD&A
Based on our historical results of operations, we expect that our cash, cash equivalents, and marketable securities cash equivalents on hand, the cash we expect to generate from operations, and funds from our Revolver, will be sufficient to fund our short-term and long-term liquidity requirements primarily arising from: research and development, capital expenditures, potential acquisitions, working capital, quarterly cash dividend payments (if such dividends are declared by the Board of Directors), share stock repurchases, outstanding commitments, and other liquidity requirements associated with existing operations.
Read it in 10-K Nov 10, 2026 at sec.gov ↗
RewordedMD&A
See Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended September 27, 2024, October 3, 2025, filed with the SEC on November 15, 2024, 7, 2025, as amended by Amendment No. 1 to such Annual Report on Form 10-K, filed with the SEC on January 24, 2025 30, 2026 (the “2024 “2025 10-K”), for Management’s Discussion and Analysis of Financial Condition and Results of Operations for the fiscal year ended September 29, 2023. 27, 2024.
Read it in 10-K Nov 10, 2026 at sec.gov ↗